Global Human Insulin Sales Market Report 2021

1 Human Insulin Market Overview

• 1.1 Human Insulin Product Scope
• 1.2 Human Insulin Segment by Type
  • 1.2.1 Global Human Insulin Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Insulin Analogs and Biosimilars
  • 1.2.3 Human Insulin Biologics
• 1.3 Human Insulin Segment by Application
  • 1.3.1 Global Human Insulin Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Short Acting
  • 1.3.3 Intermediate Acting
  • 1.3.4 Long Acting
  • 1.3.5 Pre-Mix Insulin
• 1.4 Human Insulin Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Human Insulin Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Human Insulin Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Human Insulin Price Trends (2016-2027)

2 Human Insulin Estimates and Forecasts by Region

• 2.1 Global Human Insulin Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Human Insulin Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Human Insulin Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Human Insulin Revenue Market Share by Region (2016-2021)
• 2.3 Global Human Insulin Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Human Insulin Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Human Insulin Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Human Insulin Estimates and Projections (2016-2027)
  • 2.4.2 Europe Human Insulin Estimates and Projections (2016-2027)
  • 2.4.3 China Human Insulin Estimates and Projections (2016-2027)
  • 2.4.4 Japan Human Insulin Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Human Insulin Estimates and Projections (2016-2027)
  • 2.4.6 India Human Insulin Estimates and Projections (2016-2027)

3 Global Human Insulin Competition Landscape by Players

• 3.1 Global Top Human Insulin Players by Sales (2016-2021)
• 3.2 Global Top Human Insulin Players by Revenue (2016-2021)
• 3.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2020)
• 3.4 Global Human Insulin Average Price by Company (2016-2021)
• 3.5 Manufacturers Human Insulin Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Insulin Market Size by Type

• 4.1 Global Human Insulin Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Human Insulin Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Human Insulin Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Human Insulin Price by Type (2016-2021)
• 4.2 Global Human Insulin Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Human Insulin Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Human Insulin Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Human Insulin Price Forecast by Type (2022-2027)

5 Global Human Insulin Market Size by Application

• 5.1 Global Human Insulin Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Human Insulin Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Human Insulin Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Human Insulin Price by Application (2016-2021)
• 5.2 Global Human Insulin Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Human Insulin Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Human Insulin Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Human Insulin Price Forecast by Application (2022-2027)

6 North America Human Insulin Market Facts & Figures

• 6.1 North America Human Insulin Sales by Company
  • 6.1.1 North America Human Insulin Sales by Company (2016-2021)
  • 6.1.2 North America Human Insulin Revenue by Company (2016-2021)
• 6.2 North America Human Insulin Sales Breakdown by Type
  • 6.2.1 North America Human Insulin Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Human Insulin Sales Breakdown by Type (2022-2027)
• 6.3 North America Human Insulin Sales Breakdown by Application
  • 6.3.1 North America Human Insulin Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Human Insulin Sales Breakdown by Application (2022-2027)

7 Europe Human Insulin Market Facts & Figures

• 7.1 Europe Human Insulin Sales by Company
  • 7.1.1 Europe Human Insulin Sales by Company (2016-2021)
  • 7.1.2 Europe Human Insulin Revenue by Company (2016-2021)
• 7.2 Europe Human Insulin Sales Breakdown by Type
  • 7.2.1 Europe Human Insulin Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Human Insulin Sales Breakdown by Type (2022-2027)
• 7.3 Europe Human Insulin Sales Breakdown by Application
  • 7.3.1 Europe 128 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 128 Sales Breakdown by Application (2022-2027)

8 China Human Insulin Market Facts & Figures

• 8.1 China Human Insulin Sales by Company
  • 8.1.1 China Human Insulin Sales by Company (2016-2021)
  • 8.1.2 China Human Insulin Revenue by Company (2016-2021)
• 8.2 China Human Insulin Sales Breakdown by Type
  • 8.2.1 China Human Insulin Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Human Insulin Sales Breakdown by Type (2022-2027)
• 8.3 China Human Insulin Sales Breakdown by Application
  • 8.3.1 China 152 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 152 Sales Breakdown by Application (2022-2027)

9 Japan Human Insulin Market Facts & Figures

• 9.1 Japan Human Insulin Sales by Company
  • 9.1.1 Japan Human Insulin Sales by Company (2016-2021)
  • 9.1.2 Japan Human Insulin Revenue by Company (2016-2021)
• 9.2 Japan Human Insulin Sales Breakdown by Type
  • 9.2.1 Japan Human Insulin Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Human Insulin Sales Breakdown by Type (2022-2027)
• 9.3 Japan Human Insulin Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Insulin Market Facts & Figures

• 10.1 Southeast Asia Human Insulin Sales by Company
  • 10.1.1 Southeast Asia Human Insulin Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Human Insulin Revenue by Company (2016-2021)
• 10.2 Southeast Asia Human Insulin Sales Breakdown by Type
  • 10.2.1 Southeast Asia Human Insulin Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Human Insulin Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Human Insulin Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Human Insulin Market Facts & Figures

• 11.1 India Human Insulin Sales by Company
  • 11.1.1 India Human Insulin Sales by Company (2016-2021)
  • 11.1.2 India Human Insulin Revenue by Company (2016-2021)
• 11.2 India Human Insulin Sales Breakdown by Type
  • 11.2.1 India Human Insulin Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Human Insulin Sales Breakdown by Type (2022-2027)
• 11.3 India Human Insulin Sales Breakdown by Application
  • 11.3.1 India Human Insulin Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Human Insulin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Insulin Business

• 12.1 B. Braun
  • 12.1.1 B. Braun Corporation Information
  • 12.1.2 B. Braun Business Overview
  • 12.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 B. Braun Human Insulin Products Offered
  • 12.1.5 B. Braun Recent Development
• 12.2 Becton, Dickinson
  • 12.2.1 Becton, Dickinson Corporation Information
  • 12.2.2 Becton, Dickinson Business Overview
  • 12.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Becton, Dickinson Human Insulin Products Offered
  • 12.2.5 Becton, Dickinson Recent Development
• 12.3 Biocon
  • 12.3.1 Biocon Corporation Information
  • 12.3.2 Biocon Business Overview
  • 12.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Biocon Human Insulin Products Offered
  • 12.3.5 Biocon Recent Development
• 12.4 Biodel
  • 12.4.1 Biodel Corporation Information
  • 12.4.2 Biodel Business Overview
  • 12.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Biodel Human Insulin Products Offered
  • 12.4.5 Biodel Recent Development
• 12.5 ELI Lilly
  • 12.5.1 ELI Lilly Corporation Information
  • 12.5.2 ELI Lilly Business Overview
  • 12.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 ELI Lilly Human Insulin Products Offered
  • 12.5.5 ELI Lilly Recent Development
• 12.6 Julphar
  • 12.6.1 Julphar Corporation Information
  • 12.6.2 Julphar Business Overview
  • 12.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Julphar Human Insulin Products Offered
  • 12.6.5 Julphar Recent Development
• 12.7 NOVO Nordisk
  • 12.7.1 NOVO Nordisk Corporation Information
  • 12.7.2 NOVO Nordisk Business Overview
  • 12.7.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 NOVO Nordisk Human Insulin Products Offered
  • 12.7.5 NOVO Nordisk Recent Development
• 12.8 Sanofi
  • 12.8.1 Sanofi Corporation Information
  • 12.8.2 Sanofi Business Overview
  • 12.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Sanofi Human Insulin Products Offered
  • 12.8.5 Sanofi Recent Development
• 12.9 Wockhardt
  • 12.9.1 Wockhardt Corporation Information
  • 12.9.2 Wockhardt Business Overview
  • 12.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Wockhardt Human Insulin Products Offered
  • 12.9.5 Wockhardt Recent Development
• 12.10 Ypsomed
  • 12.10.1 Ypsomed Corporation Information
  • 12.10.2 Ypsomed Business Overview
  • 12.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Ypsomed Human Insulin Products Offered
  • 12.10.5 Ypsomed Recent Development

13 Human Insulin Manufacturing Cost Analysis

• 13.1 Human Insulin Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Human Insulin
• 13.4 Human Insulin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Human Insulin Distributors List
• 14.3 Human Insulin Customers

15 Market Dynamics

• 15.1 Human Insulin Market Trends
• 15.2 Human Insulin Drivers
• 15.3 Human Insulin Market Challenges
• 15.4 Human Insulin Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List